← Evidence map

ReviewRegenerative therapy2025

CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models.

Hamid Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40837865